Evidence map›Paper›PMID 35692608›Full record

ArticlePrecision clinical medicine2020

Susceptibility-guided bismuth quadruple therapies for resistant

Tiankuo Yang, Renwei Hu, Xiaoqiong Tang, Yalin Shen, Alfred Tay, Xuenan Pi, Gang Wang, Aleksandra W Debowski, Keith A Stubbs, Mohammed Benghezal and 3 more

Open access · diamondAbstract read
In one paragraph

Article in Precision clinical medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 13 citations in OpenAlex.

  1. Overcoming antibiotic-resistantWorld journal of gastroenterology · 2025
    Review
  2. Article
  3. Article
  4. Antibiotic Resistance ofFrontiers in microbiology · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

Tiankuo YangWest China Marshall Research Center for Infectious Diseases, Center of Infectious Diseases, Division of Infectious Diseases, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, China.
Renwei HuDepartment of Gastroenterology, West China Hospital, Sichuan University, Chengdu 610041, China.
Xiaoqiong TangWest China Marshall Research Center for Infectious Diseases, Center of Infectious Diseases, Division of Infectious Diseases, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, China.
Yalin ShenWest China Marshall Research Center for Infectious Diseases, Center of Infectious Diseases, Division of Infectious Diseases, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, China.
Alfred TayHelicobacter pylori Research Laboratory, School of Biomedical Sciences, Marshall Centre for Infectious Disease Research and Training, University of Western Australia, Nedlands 6009, Australia.
Xuenan PiPrecision Medicine Key Laboratory of Sichuan Province & Precision Medicine Center, West China Hospital, Chengdu 610041, China.
Gang WangPrecision Medicine Key Laboratory of Sichuan Province & Precision Medicine Center, West China Hospital, Chengdu 610041, China.
Aleksandra W DebowskiHelicobacter pylori Research Laboratory, School of Biomedical Sciences, Marshall Centre for Infectious Disease Research and Training, University of Western Australia, Nedlands 6009, Australia.
Keith A StubbsSchool of Molecular Sciences, University of Western Australia, Nedlands 6009, Australia.
Mohammed BenghezalWest China Marshall Research Center for Infectious Diseases, Center of Infectious Diseases, Division of Infectious Diseases, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, China.
Barry J MarshallHelicobacter pylori Research Laboratory, School of Biomedical Sciences, Marshall Centre for Infectious Disease Research and Training, University of Western Australia, Nedlands 6009, Australia.
Hong LiWest China Marshall Research Center for Infectious Diseases, Center of Infectious Diseases, Division of Infectious Diseases, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, China.
Hong TangWest China Marshall Research Center for Infectious Diseases, Center of Infectious Diseases, Division of Infectious Diseases, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, China.
State Key Laboratory of BiotherapyUniversity of Western Australia · AUSichuan University · CNWest China Hospital of Sichuan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Increasing

Indexed as

antibiotic resistanceantimicrobial susceptibility testingHelicobacter pylorirescue therapywhole-genome sequencing

Identifiers

PMID35692608
PMCPMC8985787
OpenAlexW3011558560

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.